Thrombospondin-1 Deficiency Accelerates Atherosclerotic Plaque Maturation in ApoE−/− Mice
暂无分享,去创建一个
[1] C. Patterson. Angiogenesis and Atherosclerosis , 2010 .
[2] A. Kastrati,et al. Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence. , 2008, Human molecular genetics.
[3] J. Kuiper,et al. Immunomodulation of the inflammatory response in atherosclerosis , 2007, Current opinion in lipidology.
[4] M. Hoylaerts,et al. Thrombospondin-1 Activates Medial Smooth Muscle Cells and Triggers Neointima Formation Upon Mouse Carotid Artery Ligation , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[5] E. Topol,et al. Thrombospondins, their polymorphisms, and cardiovascular disease. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[6] D. Dinsdale,et al. Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet–leukocyte activation: role of P‐selectin , 2007, Journal of thrombosis and haemostasis : JTH.
[7] D. Wink,et al. Increasing Survival of Ischemic Tissue by Targeting CD47 , 2007, Circulation research.
[8] D. Schrijvers,et al. Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. , 2007, Cardiovascular research.
[9] A. Foussat,et al. Interactions between CD47 and Thrombospondin Reduce Inflammation , 2007 .
[10] P. Grimbert,et al. Thrombospondin/CD47 Interaction: A Pathway to Generate Regulatory T Cells from Human CD4+CD25− T Cells in Response to Inflammation1 , 2006, The Journal of Immunology.
[11] R. Khosravi‐Far,et al. Regulation of tumor angiogenesis by thrombospondin-1. , 2006, Biochimica et biophysica acta.
[12] J. Vermylen,et al. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. , 2006, Blood.
[13] S. Horiuchi,et al. Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-beta from its activation. , 2005, Atherosclerosis.
[14] E. Topol,et al. Thrombospondin‐1 up‐regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] M. Entman,et al. Critical Role of Endogenous Thrombospondin-1 in Preventing Expansion of Healing Myocardial Infarcts , 2005, Circulation.
[16] D. Schrijvers,et al. Phagocytosis of Apoptotic Cells by Macrophages Is Impaired in Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[17] M. Rekhter,et al. Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice , 2004, Circulation.
[18] A. Luttun,et al. Loss of Matrix Metalloproteinase-9 or Matrix Metalloproteinase-12 Protects Apolipoprotein E–Deficient Mice Against Atherosclerotic Media Destruction but Differentially Affects Plaque Growth , 2004, Circulation.
[19] J. Abe,et al. Thrombospondin 1 Is an Autocrine Negative Regulator of Human Dendritic Cell Activation , 2003, The Journal of experimental medicine.
[20] E. Topol,et al. Increased Expression of Thrombospondin-1 in Vessel Wall of Diabetic Zucker Rat , 2003, Circulation.
[21] Andreas Schober,et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E , 2003, Nature Medicine.
[22] J. Lawler,et al. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. , 2002, The American journal of pathology.
[23] G. D. De Meyer,et al. Platelet Phagocytosis and Processing of &bgr;-Amyloid Precursor Protein as a Mechanism of Macrophage Activation in Atherosclerosis , 2002, Circulation research.
[24] Alberto Smith,et al. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. , 2002, Blood.
[25] Richard J. Johnson,et al. Sustained Expression of Thrombospondin-1 Is Associated with the Development of Glomerular and Tubulointerstitial Fibrosis in the Remnant Kidney Model , 2002, Nephron.
[26] A. Tedgui,et al. Inhibition of Transforming Growth Factor- Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice , 2001 .
[27] R. Silverstein,et al. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.
[28] Jason L. Johnson,et al. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. , 2001, Atherosclerosis.
[29] C. Rahner,et al. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3. , 2000, European journal of biochemistry.
[30] M. Armant,et al. Cd47 Ligation Selectively Downregulates Human Interleukin 12 Production , 1999, The Journal of experimental medicine.
[31] R. Silverstein,et al. Angiogenesis and atherosclerosis. The mandate broadens. , 1999, Circulation.
[32] R. Silverstein,et al. Recombinant Glutathione S-Transferase/CD36 Fusion Proteins Define an Oxidized Low Density Lipoprotein-binding Domain* , 1998, The Journal of Biological Chemistry.
[33] G. D. De Meyer,et al. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. , 1998, Circulation research.
[34] R. Hynes,et al. Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo , 1998, Cell.
[35] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[36] R. Hynes,et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. , 1998, The Journal of clinical investigation.
[37] J. Isner,et al. Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries. , 1998, American heart journal.
[38] V. Swami,et al. Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia. , 1998, The Journal of surgical research.
[39] R. Hynes,et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. , 1998, Cell.
[40] C. Haslett,et al. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. , 1996, The American journal of pathology.
[41] R. Gamelli,et al. Thrombospondin 1 synthesis and function in wound repair. , 1996, The American journal of pathology.
[42] M. Rekhter,et al. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. , 1995, The American journal of pathology.
[43] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[44] V. Dixit,et al. Activated T-cell adhesion to thrombospondin is mediated by the alpha 4 beta 1 (VLA-4) and alpha 5 beta 1 (VLA-5) integrins. , 1993, Journal of immunology.
[45] A. Giles,et al. Guidelines for the use of Animals in Biomedical Research , 1987, Thrombosis and Haemostasis.
[46] R. Silverstein,et al. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. , 1987, The Journal of clinical investigation.